About
Xiaokui Zhang, Ph.D., is a biopharmaceutical R&D executive focused on cell therapy, regenerative medicine, and Parkinson's disease. She is Chief Scientific Officer at Aspen Neuroscience, where she leads current scientific programs and future platform development for the company's autologous iPSC platform. Previously, she was Executive Vice President and Chief Scientific Officer at Celularity and has also held research and development leadership roles at Celgene Cellular Therapeutics and Helicon Therapeutics.
Areas of interest
biotechcell therapyregenerative medicineParkinson's diseaseiPSCimmuno-oncologyfunctional regenerationtranslational research